Related Experiment Video
Updated: Jun 8, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA-based therapeutic approaches in the cardiovascular system
1Institute for Molecular and Translational Therapeutic Strategies, Hannover Medical School, Germany.
Abstract:
MicroRNAs (miRNAs) are endogenous small ribonucleotides that participate in the orchestration of the genome by regulating target messenger RNA translation. MiRNAs control physiological processes and misexpression of miRNAs is pathogenically involved in many diseases including cardiovascular diseases. Normalization of miRNA expression and thus downstream target networks may have enormous therapeutic chances but also risks. We here highlight and discuss recent advances in the development and use of miRNA therapeutics to target miRNAs in vivo that may translate into novel therapeutic strategies for cardiovascular diseases in the future.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
MicroRNAs
MicroRNAs
MicroRNAs
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
